CVS Health (CVS) Stock Forecast & Price Target

CVS Health is supported by a highly diversified healthcare platform that links retail pharmacy, PBM, health insurance, and delivery assets, creating complementary revenue streams and natural offsets that can stabilize earnings through changing industry conditions. Its scale is a major advantage, with about 9,000 stores, roughly 2 billion adjusted claims annually, about 26 million medical members, and over 1,000 clinics, while improving HCB margins, solid cash flow, and stronger 1Q results with revenue of $99.85B and adjusted EPS guidance of $7.30-$7.50 reinforce the recovery story. The outlook is further strengthened by specialty and mail-script growth, CostVantage and TrueCost initiatives, and early Oak Street synergies that could improve care coordination, utilization management, and long-term profitability.

CVS Health is weighed down by structural pressure across its core businesses, as PBM growth is challenged by intense competition, rebate retention risk, and mounting 340B scrutiny that could create roughly a $90MM annualized headwind and another ~$80MM risk from the proposed OPPS rule. Its retail pharmacy operations also face persistent reimbursement compression, fixed-cost deleverage, and consumer softness, while channel competition and online leaders continue to pressure front-end sales and margins. Although Aetna and Oak Street add scale, the company still needs to prove that mitigation efforts can offset these earnings drags, especially with FY27 HSS around $7.1Bn and 2028 facing an estimated ~$500MM Stars-related headwind.